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 ABSTRACT 
There exists enormous variation in estimates of the lifetime cost of obesity by race. In order to 
justify policy measures to reduce obesity rates nationally, we must first discern the cost of doing 
nothing, so this question remains imperative and unresolved. Although several researchers have 
sought to quantify obesity’s true cost stratified by race, none have produced a race-specific age-
related weight gain curve, a vital component in producing an accurate estimate. This paper 
employs a Markov model of BMI category state changes separately for black and white males 
and females from ages 18 to 75 applied to updated estimates of obesity’s costs and effect on 
mortality to quantify the median lifetime cost of obesity at age 18. It finds lower lifetime costs 
than previously, due largely to the staggering gain in weight among normal weight individuals, 
particularly among black males, that occurs in early adulthood. 
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Introduction & Background: 
 Obesity imposes an immense financial burden on the United States’ already-strained 
healthcare system with an extensive list of sequelae, including diabetes mellitus, hypertension, 
coronary heart disease, stroke, asthma, pulmonary embolism, gout, cancer, complications in 
spinal arthrodesis, and depression.7–12 In addition to these issues, obesity in youth correlates with 
higher psychological stress and impaired skill development, although this issue remains 
etiologically unclear.13–15 By the early 21st century, obesity had already become the second 
leading cause of preventable death in the US alongside tobacco, whose use has fallen 
precipitously among adolescents in recent years.16 
Policymakers seeking to curtail the spread of this disease must consider the infeasibility 
of reaching every one of the over 100 million people affected by it nationally. As a result, any 
competent intervention strategy should target a high-risk demographic responsive to 
intervention. It appears black males and females in late adolescence could fit this mold, as they 
face disproportionately high rates of obesity, weight gain occurs fastest among this age group, 
and a large amount of evidence suggests late adolescents adopt permanent lifestyle changes at far 
greater rates than younger children.1–6 However, in order to justify this intervention, we must 
first determine the lifetime costs of late adolescent obesity among black males and females in the 
US. Several researchers have sought to answer this question already; however, none have 
produced a race-specific age-related weight gain curve. 
Hypothesized Relationship: Why does the age-related weight gain curve need to be “race-
specific?” 
The importance of a race-specific age-related weight gain curves in estimating obesity’s 
costs becomes clearer when one dissects body mass index, or BMI, the indicator of obesity used 
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in this and most other studies, which has several drawbacks. Measured as weight in kilograms 
divided by height in meters squared, BMI greatly overstates the adiposity of black males and 
females, who tend to have more fat free mass than their white counterparts, which could partially 
explain why black males and females generally face lower costs associated with obesity.1,17 
Black males and females with a BMI of 30 kg/m2, for instance, may be healthier and less 
expensive than white males and females at the same level. However, they become obese at 
disproportionately higher rates than their white counterparts.18 As a result, a generic age-related 
weight gain curve not separated by race would fail to account for the far greater weight gain of 
black people over the course of their lives. This becomes especially pertinent when one considers 
most estimates of age-related weight gain until this point have relied almost entirely on data for 
white Americans, which would cause a downward bias on the estimate of costs associated with 
obesity for black males and females. 
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Literature Review 
Previous Approaches to Cost Estimation 
A longitudinal dataset that perfectly tracks changes in weight and associated costs among 
the obese over time does not exist in this country. Therefore, any study seeking to estimate 
obesity’s costs in the United States demands delicate interpretation and special attention paid to 
its assumptions. There exist three main types of study in the literature on obesity’s costs: cross-
sectional studies, which provide only a snapshot of a year or a few years of an obese person’s 
life, but dominate the literature due to their simplicity, longitudinal studies that do not consider 
age-related weight gain, and longitudinal studies that control for age-related weight gain, but do 
not separate this curve by race. 
Most Studies on Obesity’s Costs are Cross-Sectional 
While cross-sectional estimates allow us to understand the scope of the problem on a 
national scale, they reveal little of the actual cost of obesity. Obesity is a chronic and latent 
disease that becomes exponentially more expensive as the years spent with it increase, and so an 
arbitrary snapshot of a year or a few years of an obese person’s life belies its true financial 
burden. The cross-sectional approach also cannot account for changes in weight or the cost of 
obesity’s comorbidities over time, or differential life expectancies.19 Still, a majority of the 
literature consists of cross-sectional studies, and so their results provide a useful starting place. 
All of the following studies have been inflated by the medical care component of the CPI to 2017 
dollars. 
The first and lowest estimates in the cross-sectional literature come from Population 
Attributable Fraction studies, which focus on how obesity affects the prevalence of diabetes 
mellitus, coronary heart disease, hypertension, gallbladder disease, osteoarthritis, and cancer.20–22 
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Using the 1988 and 1994 NHIS, Wolf and Colditz found only 5.7% of total national healthcare 
costs were attributable to obesity, but this estimate relied on old data when obesity had not yet 
reached crisis levels.20 It also does not control for the fact that these diseases simply cost more 
for the obese than for normal weight adults because it relies on general disease cost estimates 
from other studies. Allison took the estimates of Wolf and Colditz and applied differential life 
expectancies, which resulted in a range of 0.89% to 4.32% of national healthcare costs 
attributable to obesity.21 In order to create a more accurate estimate of obesity’s costs, 
researchers next turned toward associative studies, which capture all of the costs associated with 
obesity instead of focusing only on a select number of diseases. 
Some of the earliest and most widely cited associative studies on obesity’s direct costs 
did not separate costs by race.23–26 These studies used both the self-reported data from MEPS and 
from several other surveys, notably the Healthcare for Communities and NMES, or National 
Medical Expenditure Surveys. The results rely on older data, for which obesity’s prevalence had 
not yet reached the immense levels of the present. Nevertheless, the average increase in annual 
medical spending associated with obesity ranged from $657 for inpatient and outpatient costs to 
$1,218 in total costs per year, which aggregates to 9.1% of national medical expenditures.23,24 
More significantly, for the first time in the literature, Finkelstein segregated costs by insurance 
status, and found that the public finances half of the burden of obesity.24 These studies all relied 
on the costs of obesity among Americans of all ages. Having established a more robust estimate 
for obesity’s costs through associative studies with differentiated costs by payer type, researchers 
next turned to the question of cost differences between races. 
Wee et al. published the first race-specific associative study of the cost of obesity.27 It 
used the 1998 MEPS data linked to NHIS data and ran a two-part model separately for blacks 
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and whites. It found expenditures related to higher BMI rose for male and female whites as well 
as older adults but did not for blacks or people under age 35. In fact, while the obese face mean 
per capita healthcare expenditure of $6,932, well above the $4,751.62 spent by people of normal 
weight, they found no association at all between obesity and higher costs for blacks.27 However, 
while pioneering, this study suffered from a variety of limitations, including possible bias from 
the retransformation of the two-part model; a relatively small sample of blacks; not accounting 
for costs above age 65, where obesity’s costs begin to rise rapidly; and failing to account for 
potential confounding variables that bias costs for blacks such as socioeconomic status, 
healthcare utilization, and a lower life expectancy. In order to adjust for this hidden endogeneity, 
Professor Cawley experimented with an instrumental variable approach to truly discern the 
relationship of race and obesity’s costs.28 
The Medical Care Costs of Obesity: An IV Approach represents the highest and most 
realistic of the cross-sectional estimates, with annual excess costs of $4,030 ($3,554 third party) 
per obese person.28 It used a subject’s oldest child as an instrumental variable to account for the 
underestimate of costs associated with obesity among minorities, who tend to utilize healthcare 
to a far lower extent than the national average and suffer from disproportionately high rates of 
obesity. In fact, this study found almost identical costs associated with obesity between whites 
and blacks. This resulted in the highest burden of obesity in the cross-sectional literature by far, 
with $135.53 trillion, or 20%, of all healthcare costs associated with obesity.28  
Longitudinal Studies generally don’t include age-related weight gain 
Longitudinal studies can theoretically account for the chronic nature of obesity and its 
comorbidities to produce far more accurate estimates. As noted before, there exist no datasets in 
the United States that track both BMI transitions over time and associated costs. The earliest 
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studies dealt with this discrepancy by simply not including age-related weight gain, which 
produced a severe upward bias in estimates of the cost of adolescent obesity.29–31  
The first attempt at modeling the lifetime costs of obesity focused on the relationship 
between BMI and five of obesity’s comorbidities for men and women aged 35 to 64.29,30 It 
employed simultaneous equations because the diseases act as risk factors for one another. Using 
the National Health and Nutrition Examination Survey, or NHANES III, and the Framingham 
Heart Study, Thompson employed a two-part model that first predicted the risk of each non-
cardiovascular disease at different BMIs and then predicted the risk for coronary heart disease 
and stroke incorporating the results of the first equation. This study had a host of limitations, 
including the exclusion of race as a factor, older data and a non-comprehensive list of 
comorbidities, borrowing cost data for the diseases from different studies, only focusing on three 
age brackets, and completely excluding subjects with a BMI in excess of 37.5. Still, severely 
obese men aged 45 to 54 experienced $35,194 more in medical costs than their normal weight 
peers and women faced a similar increase.29 Unfortunately, these initial “lifetime” estimates only 
measured until age 64. Naturally, researchers next explored the costs for older Americans, who 
tend to face far higher medical costs than middle-aged Americans.32 
Several studies focus exclusively on the elderly, for whom more complete data exist than 
for any other age group due to their reliance on public insurance.19,33,34 We will focus only on the 
most recent and robust estimate, which Yang and Hall authored in 2008. They rely on the 
Medicare Current Beneficiary Survey, which allows for the direct measurement of obesity in old 
age and its associated costs on a national scale. They then apply a simultaneous equation system 
approach to discern the cost of obesity among Americans aged 65 until death or 100. These 
equations determine how changes in bodyweight, chronic disease, functional status, longevity, 
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and healthcare expenditure affect and are affected by one another. Unlike in previous studies, 
they found a significant difference between genders, with overweight and obese men facing 6-
13% ($332,258 vs. $295,266) more lifetime healthcare expenditures than normal weight and 
obese women facing 11-17% more ($389,719 vs. $333,562).19 Their use of a two-part model 
with a logged OLS model and a smearing retransformation could cause potential bias.27,35 Yang 
and Hall also face many of the same limitations as previous studies on the cost of obesity for the 
elderly, namely not discussing the importance of race, short-run data, self-reported data, and the 
use of an assumption-heavy microsimulation model. Having found a competent estimate of 
obesity’s long-term costs in old age, the next step was creating an associative study that 
separated by race, instead of the limited, racially unsegregated PAF studies conducted earlier, of 
its costs over the course of a person’s life. 
The first robust associative estimate of obesity’s lifetime costs by race, Finkelstein found 
obese white males faced excess costs of $22,084 versus $33,552 for females, with obese black 
males and black females costing an excess of $17,764 and $18,850, respectively.31 He applied 
the life expectancies from his previous work on MEPS data from 2001-04 and used the 
ubiquitous two-part model with a Gamma GLM with log link to determine total costs from age 
18 until death. Although an otherwise competent estimate, Finkelstein’s omission of age-related 
weight gain makes his results difficult to rank in terms of accuracy. Nonetheless, its abiding 
popularity and focus on race-specific costs demonstrates the study’s influence. With age-related 
weight gain existing as a stark reality for which no study on lifetime costs had yet controlled, 
researchers began wondering how to account for its pervasive effects. 
Longitudinal Studies that have age-related weight gain don’t separate by race 
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 In recent years, longitudinal studies have blended together several datasets that cover 
various years and populations to assemble an age-related weight gain curve. This provides a 
robust sample and the better estimates use measured height and weight, but because of a desire to 
increase the sample size, they do not differentiate the curve by race.10,11,36–38 Therefore, none of 
the current studies provide a clear understanding of the plight of obese minority adolescents. 
Nevertheless, longitudinal studies with age-related weight gain curves have the capability of 
focusing more realistically on adolescent obesity’s effects on costs, which provides far more 
useful results. 
 The first attempt at measuring the lifetime costs of obesity controlling for age-related 
weight gain relies on data from Burton et al. 1998 to project the lifetime cost of obesity from 20 
to death.36 It relied on a multitude of sources to derive cost data, which forces heavy reliance on 
the assumptions of others. Nonetheless, it pioneered the use of a semi-Markov state-transition 
model among simulated cohorts with a BMI of 24-45 and aged 20-65 and accounted for life 
expectancy discrepancies.39 Still, the application of Heo et al. to control for age-related weight 
gain, which pieced together a variety of older data sources to predict BMI by age and sex 
irrespective of race, created only a generic age-related weight gain curve.40 In general, Tucker 
found direct medical costs increased by 2.3% for each additional BMI unit above 25, but for 
younger blacks, as BMI exceeded 40 costs actually fell.36 These paradoxical results undoubtedly 
occurred in part due to Tucker’s over-reliance on the debatable assumptions of other studies and 
generic age-related weight gain curve.31 Tucker played an important role in popularizing the 
desire to control for age-related weight gain, but further researchers would need to produce age-
related weight gain curves based on more representative and current data.  
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In 2010, Wang et al. selected a cohort aged 16 to 17 to focus on because of late 
adolescent obesity’s correlation with lifetime obesity.37 They relied on the same life expectancy 
estimates as in Finkelstein’s 2008 paper and applied the oft-used two-part model with a logit 
model then a GLM with log link focusing solely on 2000 MEPS data on costs after age 40. In 
order to control for age-related weight gain, they used the 1979 NLS Survey of Youth, which 
interviewed an older cohort that likely says little of the weight gain trajectory faced by children 
today, to track BMI changes over time. They found males cost $13,960 and females cost $12,646 
more when obese in childhood.37 The most apparent limitations are the age of the data, the use of 
only two points for BMI changes, only looking at costs after age 40, and assuming Americans 
maintain a constant weight after age 40. Wang et al. provided the first age-related weight gain 
curve produced from its own data and assumptions. In order to truly understand the effect of 
adolescent obesity on lifetime medical costs; however, researchers had to discern the costs for 
obese Americans under the age of 16. 
Later that same year, Trasande used the Nationwide Inpatient Sample from 2005, an 
enormous survey-based dataset that documents over 7 million hospital stays, as well as the 
MEPS from 2002 to 2005 to calculate lifetime costs for children aged 12 until their death, which 
were $23,307 for males and $23,377 for females.11 He accounted for age-related weight gain 
with the Fels Longitudinal Study, which began in 1929 and remarkably persists to the present.41 
Unfortunately, it primarily sampled white and suburban subjects, which makes estimating a race-
specific age-related weight gain curve impossible. Additionally, Trasande only measured age-
related weight gain at two points (ages 35 and 12), which again ignores the curve’s 
nonlinearity.11,40 Trasande also simply applied Finkelstein’s cross-sectional study discussed in 
the previous section to find the costs based on BMI and BMI transition in adulthood, a poor 
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choice given obesity’s chronic nature. All of the above studies relied on age-related weight gain 
estimates derived from either older, unrepresentative datasets or at only two points in an obese 
American’s life. Last year, Fallah-Fini pioneered the first age-related weight gain based on 
current data over the course of a person’s life.10 
Most recently, Fallah-Fini used a Markov model that found lifetime third party costs for a 
20-year-old with obesity of $14,412 compared to $16,325 for those aged 50.10 This discrepancy
results from the discounting of future costs, most of which subjects face later in life. While still 
unseparated by race, Fallah-Fini’s age-related weight gain estimate relied on the most recent and 
robust data available with the CARDIA study for weight gain below age 45 and ARIC for weight 
gain above 45. Unfortunately, the study only considers the comorbidity with the highest cost 
even if the subject has multiple, which likely substantially understates true costs. Additionally, 
the study only accounts for four obesity-related outcomes, has no racial component, and assumes 
disease independence. Still, for the first time a study modeled age-related weight gain over the 
course of an entire lifetime with current data, and the study demonstrated that state transitions 
most significantly burdened third-party payers. 
Motivation 
Numerous studies have sought to quantify both the direct and indirect costs of obesity. 
Unfortunately, the few that account for age-related weight gain, a pivotal part of any estimation, 
rely on older or unrepresentative datasets.11,19,36,38–41 This becomes especially crucial as several 
studies have found that weight gain over time explains the majority of costs associated with 
obesity borne by third party payers.10 More damning still, many of these estimates fail to account 
for the huge disparities in weight gain between races and produce estimates at only two ages, 
which does not properly represent the nonlinear shape of the trend.11,13,27,36,37,42 Without this 
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racial trend or using only a linear trend, these studies produce no practical interpretation of late 
adolescent obesity’s costs for minorities. In order to rectify this omission, this study will create a 
race-specific age-related weight gain curve to produce the first lifetime estimate of obesity that 
considers the rapidity with which minority adolescents gain weight as they age. It will show that 
the costs faced by this group justify targeting them for intervention efforts. 
Data 
Criteria for Datasets in the Age-Related Weight Gain Curve 
Unfortunately, the lack of a recent, robust estimate of race-specific age-related weight 
gain stems from the limitations of available racially diverse longitudinal studies in America. 
Ideally, this longitudinal dataset would be nationally representative, recent, and cover subjects 
from early adolescence until their deaths. Because such a dataset simply does not exist in this 
country, we created a list of criteria to determine whether a dataset deserves inclusion in this 
study despite its shortcomings. Most importantly, the dataset must contain a sufficient number of 
minority subjects to produce statistically powerful estimates. Other criteria include that the 
dataset covers over ten years of subjects’ lives, is relatively recent, has sufficient follow-up and 
low attrition rates, covers a unique age range, has a short time between observations and 
objectively measured height and weight, and is nationally representative. The datasets that better 
fit these criteria received heavier weighting in the curve. All told, we made use of three datasets: 
the Framingham Heart Study (FHS), Coronary Artery Disease Risk in Young Adults (CARDIA), 
and the Atherosclerosis Risk in Communities Study (ARIC). 
The Framingham Heart Study 
Perhaps the most famous of the five major longitudinal population health studies in the 
United States, the Framingham Heart Study began with a predominately white cohort in 1948 in 
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Framingham, Massachusetts and continues to this day.30 Unfortunately, the study did not begin 
reflecting the health trajectories of minority subjects until 1994, when the OMNI cohort was 
established to reflect Framingham’s shifting demographics.43 Despite biennial observations, FHS 
has several drawbacks, including covering too few minority subjects, representing only one city, 
covering minority subjects for just over 20 years, and having recent observations only for middle 
to older aged subjects. As a result, while a robust dataset with over 5,000 subjects even in the 
initial cohort, we decided not to use FHS to aid in the estimation of curves.30 Instead, this data 
proved invaluable in testing the external validity of our methodology as a comparison group to 
white subjects in other datasets. 
Coronary Artery Disease Risk in Young Adults 
 In an attempt to create a more representative sample, CARDIA, which began in 1985 and 
ended in 2005 with its fifth and final examination, observes the progression of Coronary Artery 
Disease in four population centers, including Birmingham, Chicago, Minneapolis, and Oakland.45 
The study enrolled over 5,000 black and white men and women from a variety of regional and 
sociodemographic situations, with 72% of the group remaining until 2005.46 As one of the few 
nationally representative and racially diverse datasets available, the inclusion of CARDIA in our 
estimation was practically obligatory. CARDIA focuses predominately on the time period after 18 
years of age until middle age.10 
Atherosclerosis Risk in Communities Study (ARIC) 
 Analogously to CARDIA, ARIC takes subjects from four population centers: Minneapolis, 
Minnesota; Hagerstown, Maryland; Forsyth County, North Carolina; and Jackson Mississippi.47 
One of the largest longitudinal population health datasets in American history, ARIC, which began 
in 1987 and has conducted five examinations to date, boasts over 15,000 subjects pulled relatively 
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evenly from each of these centers.48 Because of its size, recency, and national representation, ARIC 
was included in the estimation of the curve and is weighted heavily. The dataset focuses primarily 
on subjects aged 45 to 64. Unfortunately, ARIC switched to phone interviews in 1998, at which 
point weight and height became self-reported and no longer fit the criteria for inclusion in this 
study.10 
Data for Costs of Obesity 
Medical Expenditure Survey (MEPS) 
Beginning in 1996, the Medical Expenditure Survey, or MEPS, is the most detailed 
analysis of healthcare cost and utilization among noninstitutionalized Americans presently 
available.  Far and away the most commonly used dataset for US medical expenditures, MEPS 
consists of a two-year panel design, where subjects report on diseases, health care costs, payment 
methods, and hundreds of other questions.28 Unfortunately, although costs come directly from 
payers and households, subjects self-report height and weight. In order to account for this, we 
eliminated biologically implausible BMIs, which we defined as subjects with z-BMIs in excess 
of positive or negative four in accordance with the WHO’s recommendations.49 
We use data from the waves 2014 through 2016, with all costs inflated to 2016 dollars by 
the Medical Component of the CPI.50 Because all costs focus on third party payers, we remove 
out of pocket costs from total expenditures. MEPS data makes use of a stratified multi-stage 
probability design to ensure subjects receive weights that make them nationally representative.51 
This cluster design, in which like subjects are grouped into strata, violates the independent and 
identically distributed observations assumption fundamental to the traditional calculation of 
standard errors.52 We account for this cluster design through Stata’s complex survey design 
tools, which correct for the unorthodox sampling plan, with singleton Primary Sampling Units 
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caused by data sub setting centered to the overall sample mean to allow for variance 
estimation.53,54 Additionally, because we pooled data from 2014 and 2016, we applied a standard 
correction recommended by both the CDC and in William G. Cochran’s seminal book Sampling 
Techniques of dividing the weights by the number of years pooled.55 This approach also makes 
intuitive sense because since each survey represents the entire nation, any additional year added 
would cause the weighted observations to double the population of the country. 
Differential Life Expectancies Data 
Public Use National Health Interview Survey (NHIS) and Corresponding Linked Mortality Files 
Commissioned by the US Census Bureau, the NHIS studies a range of health behaviors 
and characteristics. Recently, the National Center for Health Statistics (NCHS) has made public-
use Linked Mortality Files (LMFs) available through the year 2014 that utilize data from the 
NHIS to link to files from the comprehensive National Death Index. As a result, we make use of 
data from the years 1997 to 2014 in an effort to update recent work on life expectancy that relied 
primarily on data from the 1990s. Although public use data is subject to data perturbation for 
anomalous causes of death and location censoring, our predominant focus on only vital status 
renders these limitations bearable. Our primary concern in using these data is self-reported height 
and weight, but these limitations remain a stumbling block for all researchers. 
National Lifetables 
In order to provide a basis from which to create BMI-specific life expectancies, we use 
the official 2015 US Lifetables provided by the NCHS and separated by race and gender. We 
will apply hazard ratios associated with different levels of BMI to these estimates to discern the 
impact of BMI on life expectancy separately by race and gender. 
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Methodology1 
Estimating Age-Related Weight Gain 
Formal Model Specification 
𝜀𝑡+1 = 𝑃𝜀𝑡 + 𝑣𝑡+1 (1) 
Where 𝜀𝑡+1 is current time period, 𝜀𝑡 is previous time period, and 𝑣𝑡+1 is the innovation, which should have a mean of zero and random variance 
(White Noise Process) if the forecast is robust.56 
We make use of a four-state Markov model to estimate age-related weight gain over the 
course of each subject’s life. The states consist of the widely-agreed upon BMI categories for 
underweight (under 18 kg/m2), normal weight (from 18 to 25 kg/m2), overweight (from 25 to 30 
kg/m2), and obese (greater than or equal to 30 kg/m2).57 Four different iterations of the model 
exist in total, with subjects separated both by gender and race. A Markov process is 
“memoryless” in the sense that the only data used to make an estimation are from the previous 
state, which means it can be represented by the First Order Difference Equation below:58,56 
𝑥𝑘+1 = 𝑃𝑥𝑘 (2) 
Where xk+1 represents the next observation, xk represents the current state, and P represents a stochastic transition probability matrix 
This modeling technique has a long history in the study of BMI transition 
estimation,10,36,38,59 but also makes sense to use intuitively. Because of the relative intractability 
and consistency of age-related weight gain, a subject’s weight in the last time period likely 
correlates extremely powerfully with their current weight.60 An obese or overweight adult rarely 
goes back down to a lower BMI category, and almost never sustains this weight loss, which 
makes their history of weight prior to the latest period largely irrelevant.34 Moreover, our 
decision to use a relatively short gap of three years between observations suggests BMI likely 
1 Note: In an effort to encourage reproducibility and transparency, both the age-related weight gain curve and cost 
estimates were run on randomly generated data, and then posted on Open Science Framework. 
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changes only gradually from the previous time period and multiple state transitions in such a 
short period of time seem unlikely. These state transitions for subjects allow us to form a 
stochastic state transition probability matrix, from which the probability of shifting from one 
BMI category to another based on current BMI and age can be elucidated over the course of 
every subject’s life. 
An advantage of our approach compared to some of the existing literature is that we let 
the data dictate the formation of these state transition probability matrices instead of relying on 
previous estimates, which introduce potential bias from the imperfect study designs of others and 
are often less current.10,13,61 As discussed earlier, we tested the external validity of the model 
with an out of sample group of white males and females in the FHS.42 All estimates are state and 
age-specific, with pregnant subjects dropped and no other covariates. The country’s recent 
secular trend in weight gain, wherein people of every age weigh more than they did previously, 
could introduce bias.62 However, because we construct these curves from observations of real 
people over time and more recent observations receive heavier weighting, it still serves the 
purpose of accurately modeling real world weight gain trajectories. 
In order to calculate 95% confidence intervals, we performed 1,000 bootstrapped 
iterations of the original state transition intensity matrix and plotted the confidence intervals on a 
histogram to ensure the iterations achieved maximum likelihood (through the production of 
bimodal distributions). We had to bootstrap because our confidence intervals came from the 
Hessian matrix for asymptotic standard errors, with the asymptotic approximation becoming 
more accurate as the iterations increased, although negligibly past 1,000 iterations.  
Age-related Weight Gain Curve Weighting and Age Groups 
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Because of both data limitations and similarities in weight gain between certain ages, we 
grouped subjects in each dataset into age categories. We determined these age categories both by 
biological intuition and data availability. CARDIA, which has subjects aged 18 to 55, allowed 
for relatively large age brackets. Because ones individual health behavior remains largely 
stagnant after their twenties, there exists a great deal of consistency between one’s twenties and 
thirties, and so the first age group is from ages 18 to 35. Although one’s metabolism generally 
slows and testosterone declines around thirty, these effects tend to take years to fully play out.65 
Similarly, the next age group, 36 to 45, consists of people in similar life circumstances and 
biological realities. The final CARDIA group, aged 46 to 55, attempts to capture changes in 
weight that may result in being at the advanced stage of one’s career.  
Lastly, ARIC, which covers subjects aged 44 until their late nineties, produces a decade 
of overlap with CARDIA. Because of CARDIA’s more recent data (up to 2011 compared to 
1998), it receives weighting of 70% compared to 30% for ARIC. The overlapping group, ages 44 
to 55, produced relatively consistent estimates between the datasets, so the exact level of 
weighting matters little. ARIC adds the age groups 56 to 64 and 65 to 74. Unfortunately, none of 
the datasets provide a sufficiently large sample for estimates above 75 years of age. As a result, 
we transition subjects to their original BMIs at this point, which is an assumption that requires 
further analysis. 
In order to generate median estimates, we took the total product of the probability of 
remaining in the current BMI status every three years until this number declined to less than 
50%, at which point a subject transitioned to the next most probable state. These estimates are 
contrasted with the upper and lower bounds of the 95% confidence interval in the appendix. 
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Estimating Obesity-related Costs 
 As is convention with highly skewed healthcare data, we run a two-part model (2PM) on 
the probability of any medical expenditures and then the total medical expenditures conditional 
on having any.28,26,27,66-67,19 We chose this model because the large number of subjects with no 
medical expenditures in any given year would severely bias our results with only one model on 
total medical expenditure. We control for MEPS’s complex survey design as described above, so 
all standard errors and confidence intervals are subject to this adjustment.  
 For the first part of the model the dependent variable, whether a subject reports any 
medical expenditure, will have a binomial distribution.2 In order to regress a binary variable, we 
use a generalized linear model, where a link function transforms the binomial distribution into an 
approximately normal distribution. The two most popular versions of this model are the Logit 
and Probit. There exist relatively few practical differences between these models: a logistic error 
term’s distribution normally has a higher kurtosis, interpretations of the coefficients vary, and 
slight differences in model fit exist. Because the distinction matters little, we decided to use a 
logit model because of its marginally superior fit and relative ease of interpretation. 
First Equation 
P(Medical Expenditurei = 1) 
=
𝒆𝑿𝜷
𝟏+𝒆𝑿𝜷
(𝟑) 
Xβ = β0 + β1BMICategoriesi + β2Educationi + β3Rurali + β4Smokeri + β5InsuranceStati + β6Educationi + 
β7MarriageStati + β8Regioni + β9Agei + β10BMICatsXAgei + β11Age2i + β12Age3i + β13Pregi + εi 
  
                                                          
2 𝑃(𝑋 = 𝑥) = ∑ (𝑛
𝑥
)𝑝𝑥(1 − 𝑝)𝑛−𝑥
𝑛
𝑥
 Binomial Probability Mass Function. N options choose x at the beginning of 
the formula suggests a constant level of n and x, which is because an experiment is conducted under identical 
conditions (or “with replacement”). 
Schell 19 
 
 Our decision on the functional form of the second part of the model proved more 
nuanced. The two most commonly used modeling approaches are a Generalized Linear Model 
(GLM) with a Gamma Log Link and a Logged OLS regression. These discussions can 
sometimes feel a bit murky, so we think a helpful analogy to understand the distinction between 
a GLM and an OLS model is the difference between a rectangle and square. An OLS model is a 
GLM that requires a normal (or in this case lognormal) distribution, like how a square is a 
rectangle that requires equal side lengths, whereas in the general case a GLM, like how a 
rectangle does not require a square’s assumptions, can fit with both normal and non-normal 
distributions. Thus, the GLM requires no retransformation and has more relaxed assumptions 
than an OLS model, such as not requiring a lognormal distribution, but provides less statistical 
efficiency. Meanwhile although a logged OLS model brings in the upper tail of the distribution 
and accounts for the extreme range of healthcare data to some extent, it also requires a smearing 
retransformation, which could cause bias in the presence of heteroskedasticity.68 We used a 
histogram of expenditure data and ran Park tests to determine that the lognormal distribution fit 
the data best, so we chose the logged OLS model. 
Second Equation 
𝑳𝒐𝒈𝒈𝒆𝒅 𝑪𝒐𝒏𝒅𝒊𝒕𝒊𝒐𝒏𝒂𝒍 𝑴𝒆𝒅𝒊𝒄𝒂𝒍 𝑬𝒙𝒑𝒆𝒏𝒅𝒊𝒕𝒖𝒓𝒆𝒔 = 𝑿𝜷 (𝟒) 
Xβ = β0 + β1BMICategoriesi + β2Educationi + β3Smokeri + β4InsuranceStati + β5MarriageStati + β6Regioni + 
β7Agei + β8BMICatsXAgei + β9Age2i + β10Age3i + β11Pregi + εi 
 
 We run the 2PM separately by race and gender, with all medical expenditures inflated to 
2016 dollars through the medical component of the CPI and discounted at a 3% discount rate 
over the course of a subject’s life.  
 Variable selection was identical between the two equations. We control for education 
through Bachelor’s and Graduate Degree dummy variables, whether a person smokes, their 
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current insurance status (with uninsured as the omitted category), their marital status (with single 
as the omitted category), their census region (with South as the omitted category), their age as a 
continuous variable, an interaction between their BMI category and age, quadratic and cubic age 
variables, and a variable for whether a person is currently pregnant. The key variable, BMI 
category, relies on the same categories as described earlier (underweight, normal weight, 
overweight, obese), with obese as the omitted category. 
Differential Life Expectancies 
 Naturally, a lifetime cost estimate must control for the possibility that obese people do 
not live as long as their normal weight counterparts and, hence, cost less. Unfortunately, the 
existing literature on the life expectancy penalty resulting from obesity relies on largely older 
data and has provided equivocal results. In fact, some studies even found an “obesity paradox” 
among black males, wherein the obese outlive those of normal weight.36 This undoubtedly has to 
do with some form of endogeneity, and we cannot preclude such an issue from existing in our 
own study. However, to provide an authoritative and more recent view of the subject, we have 
decided to update life expectancies by using interview data from 1997-2014 with mortality 
follow-up through 2015, the latest time period used for such a study to date. 
 We first found the age-specific death probabilities of black and white men and women in 
the official 2015 US Lifetables published by the NCHS.69 Unfortunately, these data do not 
account for specific BMI categories and smoking status, an enormous potential confounder in 
life expectancy. As a result, we created a Cox proportional hazards model run separately by race 
and gender with NHIS data from 1997-2014 and linked it with corresponding Linked Mortality 
Files in the National Death Index until 2015. The output produced by a Cox proportional hazards 
model, a hazard ratio, illustrates the changed hazard of an outcome occurring from a change in 
Schell 21 
characteristics. For instance, a hazard ratio of three for an obese person would suggest that they 
have triple the chance of dying that year compared to a reference normal weight person with 
otherwise identical attributes. Thus, in order to determine BMI’s effects on life expectancy by 
age, we will apply the hazard ratios of each BMI and smoking category to the probability of 
death at any age. 
Once again, the complex survey design and clustering necessitated the use of complex 
survey design commands in Stata. However, because the sample design changed in 2006, we 
also had to alter the strata and primary sampling units to maintain statistical independence 
between these differing sampling plans. Additionally, the pooling of nationally representative 
data over 18 years required us to divide the weighting variable by the number of years in the 
pool, as detailed previously. The end result was a survey of 500,121 respondents, of whom 
61,552 died by the year 2015. 
We applied the same BMI categories as used in the rest of the study; however, we also 
had to account for smoking as a potential confounder. We classified people as never smokers, 
current smokers, or, if they smoked at least 100 cigarettes in their lives, former smokers. The 
covariates were the BMI categories with normal weight as the reference group, smoking status 
with never smokers as the reference group, and interaction terms between disproportionate BMI 
groups (which varied by race) and age, since the effects of smoking and BMI both tend to 
diverge later in life. 
Unlike in previous work, we found several points at which the proportional hazards 
assumption would be violated according to Schoenfeld residuals and log-log plots.31,39 There 
exist two common methods for handling disproportionality – an interaction between the violating 
variable and time and stratification by the variable.70 Because stratification does not allow for 
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estimation of a parameter value (and we need such a value to accurately assess life expectancy 
effects) and causes less efficiency, we added interaction terms between age and each violating 
variable. This adjustment also makes intuitive sense, as BMI’s impact differs markedly based on 
one’s age and time spent in each state, so age interactions should provide a more precise 
estimation of its impact on survival probability over time. 
After conducting likelihood ratio tests for the interaction model and Wald tests for the 
joint significance of the interaction variables and analyzing AIC and BIC criterion for goodness 
of fit, we confirmed the logic behind this intuition. In the interest of comparability with 
Finkelstein’s article, which focused on data from 1988 to 2002, we also ran the model for the 
years 1990 to 2005 (excluding 1996 for lacking smoking data) and attached the results in the 
appendix. 
Cox Proportional Hazards Model 
ℎ(𝑡) = ℎ0(𝑡)𝑒
(𝑋𝛽) (5) 
where Xβ = β0 + β1Age + β2Age2 + β3BMICats + β4SmokingStat + β5AgexSmokingStat + β6AgexBMICats + ε 
h0(t)=reference group (normal weight person with otherwise identical characteristics) 
h(t) = hazard ratio 
Before we could apply these hazard ratios to the lifetable to create BMI-specific death 
probabilities, we had to determine the probability of being in each BMI category by age. Thus, 
we created a multinomial logit with the 12 possible combinations of BMI category and smoking 
status as the dependent variable and age, age squared, and age cubed as the independent 
variables. These estimates reflect the most recent national prevalence rates and, hence, rely on 
data pooled data from 2012 to 2014. They were not run separately by age group due to an 
insufficient sample size and desire for an efficient estimate. 
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Multinomial Logit on Probability of Being in Any Particular BMI Category 
𝑷𝒊𝒋 =
𝒆(𝜶+ 𝑿𝒌𝒋𝒊𝜷𝒌𝒋)
𝟏 + ∑ 𝒆∑ 𝜶+𝑿𝒌𝒋𝒊𝜷𝒌𝒋
𝑲
𝒋=𝟏𝑱
𝒋=𝟏
(𝟔) 
Xβ = β0 + β1Agei + β2Age2i + β3Age3i + εi 
We calculated BMI-specific death probabilities for each race and gender group by 
multiplying the unadjusted probabilities in the lifetables by an adjustment factor. This adjustment 
factor equaled the hazard ratio of a particular BMI and smoking-status at a specific age divided 
by the sum of the product of the hazard ratios and probability of being in each BMI and smoking 
status category for that same age.  
𝜃𝑖𝑗𝑘 = 𝜃𝑗
ℎ(𝑡)𝑖𝑗𝑘
∑ ∑ 𝑃𝑖𝑗𝑘ℎ(𝑡)𝑖𝑗𝑘
4
𝑗=1
3
𝑘=1
(7) 
After collecting these death probabilities, we simply took the product of the survival 
probabilities at each age (1-𝜃𝑖𝑗𝑘) until the cumulative probability of survival became less than
0.5 to produce median life expectancy. We then subtracted the life expectancy of an obese 
person from that of a normal weight person with otherwise matching characteristics to produce 
Years of Life Lost (YLLs) from obesity for each smoking category. Table 2 illustrates these 
results by smoking status, although we will focus on the effect on non-smokers for the sake of 
consistency. 
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Unadjusted Cost Estimates 
Given the complexity of the methods that have produced our estimates, we have decided 
to focus the results section on a case study of obesity’s lifetime effects: a publicly insured 18-
year-old of each race and gender who is normal weight compared to an otherwise identical obese 
teenager. Table 1 suggests that our excess cost estimates for white males and females before 
applying age-related weight gain are only somewhat conservative compared to the existing 
literature. However, black males and females face markedly lower excess costs than past 
estimates suggest. This likely has to do with our decision to focus on people of identical 
insurance status, as the high number of black males and females who remain uninsured would 
otherwise skew our estimate of obesity’s true cost. Because of cost discounting, the cost for 
every group becomes higher the later in life they remain obese, with the immense disparity in 
excess costs faced between races disappearing entirely by age 60. Unfortunately, the discrepancy 
among younger people by race probably results from a lower level of healthcare access and 
utilization among black compared to white people.71 However, obesity’s prevalence nationally 
among black males and females remains substantially higher than for their white counterparts.5 
Additionally, if our age-related weight gain curves suggest a higher rate of persistence among 
blacks suffering from obesity, these estimates could prove misleading regarding obesity’s true 
cost within the black community. For full cost regression results, consult the appendix. 
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Table 2: Median Life Expectancy Comparison 
Life Expectancy at Age 18 
Never Smokers Current Smokers Former Smokers 
Normal Weight Overweight Obese Normal Weight Overweight Obese Normal Weight Overweight Obese 
Black Males 76 80 78 68 71 69 73 76 75 
White Males 82 84 81 72 74 70 79 81 78 
Black Females 82 84 82 75 77 74 80 82 80 
White Females 86 86 84 77 78 75 83 83 81 
Note: "Protective" Result for Obese Black Males likely due to Endogeneity 
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Unadjusted Life Expectancy Estimates 
Although smoking remains more damaging in terms of life expectancy effects, obesity causes a 
loss of at least one year of life at age 18 for every group except black males, for whom obesity appears 
protective. This spurious result has occurred elsewhere in the literature and probably results from some 
form of endogeneity, wherein obese black males have certain characteristics that serve to counteract 
the disease’s deleterious effects.36 Additionally, unlike previous articles that explored the impact of 
obesity levels beyond 30, data constraints for our age-related weight gain curve force us to focus on 
even the relatively mild cases with sub-35 BMIs. Obese white females face the harshest survival penalty 
of two years of life lost at age 18 regardless of smoking status, while white males consistently face a loss 
of one year and black females face a loss of several months to a year depending on smoking status. Like 
the cost estimates, these life expectancies appear somewhat conservative in measuring obesity’s impact 
compared to previous attempts. While this could simply be an artifact of the data, there also exists a 
real possibility that an ever-improving repertoire of medicines to combat obesity’s comorbidities that 
have proliferated over the previous decades has caused this decrease in obesity’s lethality.72  
Age-Related Weight Gain Estimates 
The two-period moving average graphs in the appendix depict BMI state transitions from age 18 
until 75 for each of the four race and gender groups, as well as the upper and lower bounds of the 95% 
confidence intervals. Although the graphs look broadly similar, one of the most powerful results occurs 
among normal weight black males. While the other three groups have a lower bound confidence interval 
that lags slightly behind the point estimate of weight gain, the lower bound and point estimate among 
normal weight black males move in lockstep until middle age. The remarkable precision of this estimate 
indicates a degree of inevitability in weight gain unique to black males. However, more worryingly, 
normal weight black males and females share a steep gain in weight during their mid-late twenties, and 
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subsequently become obese an average of a full decade before their white counterparts. For the 
transition probability matrices, consult the appendix. 
Age-Related Weight Gain Adjusted Life Expectancies 
After incorporating the age-related weight gain trajectories into the previous life expectancy estimates 
from age 18 until death, the survival gap between obese and normal weight people lessens 
considerably. Previously enjoying a survival advantage of 2 years, obese black males now live an 
identical amount of time as if they were normal weight. This result stems from the speed with which the 
average black male of normal weight becomes overweight and then obese, which means both groups 
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spend the majority of their lives obese. On the other hand, obese white males actually gained a survival 
advantage over their normal weight peers of one year. This is undoubtedly the product of obese males 
temporarily moving back down to the overweight category, the group with the highest overall life 
expectancy. Obese black females faced a decreased life expectancy of only a few months, while obese 
white females now have a life expectancy disadvantage of only one year.  
Final Cost Estimates 
After adjusting for age-related weight gain, the excess costs associated with obesity fell for each group, 
with only obese white women facing excess costs beyond $10,000.  These results put our excess cost 
estimates far below most other work in the literature. However, this result speaks more to the latent, 
backloaded nature of obesity’s costs and the effect of cost discounting. For instance, an obese 76-year-
old black male faces undiscounted medical expenses in excess of $5,000 in a single year. However, 
discounting from 18 years of age decreases this effect to just over $1,500.  Likewise, because black 
males live significantly shorter lives than their white counterparts, they have less time over which to 
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accumulate more medical expenses. Medical professionals, public health advocates, and community 
organizers across the country have worked ardently to reduce this health disparity, which should only 
increase the cost of obesity in the future. If black males lived as long as their white counterparts, they 
would face additional discounted excess costs of $4,173.64, or $8,145.71 in excess costs total. The 
somewhat lower cost of obesity among black males should be viewed as a sign of our nation’s public 
health shortcomings rather than as a justification for complacency. Additionally, when dissecting these 
estimates, one must recall that age-related weight gain did not lower the immense cost of obesity, 
rather, it elevated the true cost of the disease given the remarkably high probability that anyone 
regardless of race or sex will eventually become obese.  
Limitations 
These results present several limitations and avenues for further research. Firstly, it appears the 
decision to use 30 BMI as a cutoff for obesity has caused conservative estimates. Likewise, our decision 
to bin ages and BMI categories, while necessary, does reduce the efficiency of the estimate. 
Additionally, because there exists no dataset with which we can determine time spent with obesity, 
which research has shown to substantially increase costs, these estimates should be viewed as an 
absolute lower bound.73 We also rely on median estimates of state transition, but weight gain trajectory 
remains a highly individual process, and simulation studies should be performed to determine the 
impact of a change in assumptions on weight gain. Lastly, our age-related weight gain only went until 
age 75, after which some of the most vital years of life in terms of cost occur. 
Discussion 
This estimate provides policymakers context for a conservative cost-benefit analysis of obesity-focused 
interventions. We discovered that, while record numbers of adolescents suffer from obesity, an 
enormous portion of obesity’s prevalence, and therefore cost, comes from age-related weight gain in 
early adulthood. The situation appears especially dire for normal weight black males and females at age 
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18, who on average face the prospect of obesity a full decade before their white counterparts.  When 
other studies rely only on white subjects to estimate age-related weight gain, they miss this fact entirely 
and subsequently overestimate the lifetime cost of late adolescent obesity and underestimate the cost 
of normal weight black males and females, for whom facing obesity later in life is almost an inevitability. 
This suggests that the issue of differential obesity levels between white and black males and females 
remains a problem even after adolescence, and further research should be conducted to discover the 
determinants of this weight gain later in life and whether preventative efforts in adolescence to reduce 
obesity in later life among black males and females could prove feasible. Unfortunately, the relatively 
low cost of obesity among black males also points to an area in serious need of continued research: 
health disparities between races. Black males live shorter lives and gain weight at faster rates than any 
of the other groups analyzed, which suggests health outcomes in this country still run strongly on racial 
lines. Far from  a justification for complacency in the face of the obesity epidemic, these  lower lifetime 
costs of late adolescent obesity speak to  the troubling persistence of the threat of obesity throughout 
the lives of black males and females, which will require enormous creativity from policymakers to 
rectify.
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Transition Probability Matrices 
Black Males Ages 18 to 35 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0 0 0
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0 0.77 (0.75, 0.79) 0.20 (0.18, 0.22) 0.03 (0.02, 0.03)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0.08 (0.06, 0.10) 0.72 (0.69, 0.75) 0.20 (0.17, 0.22)
𝑂𝑏𝑒𝑠𝑒 0 0.006 (0.004, 0.008) 0.09 (0.07, 0.12) 0.90 (0.87, 0.92)]
White Males Ages 18 to 35 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0 0 0
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0 0.80 (0.78, 0.82) 0.19 (0.17, 0.21) 0.01 (0.01, 0.02)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0.12 (0.10, 0.14) 0.77 (0.75, 0.80) 0.11 (0.09, 0.13)
𝑂𝑏𝑒𝑠𝑒 0 0.008 (0.005, 0.01) 0.11 (0.07, 0.14) 0.88 (0.85, 0.92)]
Black Females Ages 18 to 35 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.45 (0.35,0.56) 0.47 (0.38,0.55) 0.07 (0.05,0.08) 0.01 (0.008,0.01)
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.007 (0.003,0.01) 0.76(0.74, 0.78) 0.19 (0.17, 0.21) 0.04 (0.04, 0.05)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.0006 (0.0003,0.001) 0.12 (0.1, 0.14) 0.60 (0.57, 0.62) 0.29(0.26, 0.31)
𝑂𝑏𝑒𝑠𝑒 0.00002 (0.00001, 0.00005) 0.007 (0.005, 0.01) 0.07 (0.06, 0.09) 0.92 (0.90, 0.94) ]
White Females Ages 18 to 35 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.25 (0.16,0.35) 0.69 (0.60,0.77) 0.055 (0.04,0.07) 0.006 (0.004,0.007)
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.02 (0.01,0.02) 0.86 (0.85, 0.87) 0.11 (0.09, 0.12) 0.02 (0.01, 0.02)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.003 (0.002,0.004) 0.20 (0.17, 0.23) 0.60 (0.56, 0.64) 0.20 (0.17, 0.23)
𝑂𝑏𝑒𝑠𝑒 0.0002 (0.00009,0.0002) 0.02 (0.01, 0.02) 0.11 (0.08, 0.14) 0.87 (0.84, 0.91) ]
Black Males Ages 36 to 45 (CARDIA) 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0 0 0
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0 0.80 (0.75, 0.85) 0.18 (0.14, 0.23) 0.01 (0.01, 0.02)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0.09 (0.06, 0.11) 0.79 (0.75, 0.82) 0.13 (0.10, 0.16)
𝑂𝑏𝑒𝑠𝑒 0 0.004 (0.002, 0.01) 0.05 (0.03, 0.07) 0.95 (0.92, 0.97)]
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White Males Ages 36 to 45 (CARDIA) 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0 0 0
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0 0.82 (0.79, 0.85) 0.17 (0.14, 0.20) 0.01 (0.008, 0.01)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0.04 (0.03, 0.06) 0.85 (0.82, 0.87) 0.11 (0.09, 0.13)
𝑂𝑏𝑒𝑠𝑒 0 0.003 (0.0007, 0.01) 0.06 (0.03, 0.09) 0.94 (0.91, 0.97) ]
Black Females Ages 36 to 45 (CARDIA) 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0 0 0
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0 0.76 (0.71, 0.80) 0.21 (0.17, 0.25) 0.03 (0.02, 0.04)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0.07 (0.04, 0.09) 0.72 (0.68, 0.76) 0.21 (0.18, 0.25)
𝑂𝑏𝑒𝑠𝑒 0 0.003 (0.002, 0.007) 0.05 (0.04, 0.07) 0.94 (0.93, 0.96)]
White Females Ages 36 to 45 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0 0 0
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0 0.88 (0.86, 0.90) 0.11 (0.09, 0.13) 0.01 (0.008, 0.01)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0.07 (0.05, 0.10) 0.77 (0.73, 0.81) 0.16 (0.12, 0.19)
𝑂𝑏𝑒𝑠𝑒 0 0.03 (0.01, 0.05) 0.04 (0.02, 0.06) 0.93 (0.90, 0.96) ]
Black Males Ages 46 to 55 (CARDIA) 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0 0 0
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0 0.80 (0.70, 0.89) 0.19 (0.10, 0.29) 0.009 (0.004, 0.02)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0.06 (0.02, 0.11) 0.85 (0.80, 0.91) 0.09 (0.04, 0.13)
𝑂𝑏𝑒𝑠𝑒 0 0.006 (0.0003, 0.02) 0.03 (0.006, 0.05) 0.97 (0.94, 0.99) ]
White Males Ages 46 to 55 (CARDIA) 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0 0 0
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0 0.86 (0.81, 0.91) 0.13 (0.08, 0.18) 0.008 (0.005, 0.01)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0.053 (0.03, 0.08) 0.84 (0.80, 0.88) 0.10 (0.07, 0.14)
𝑂𝑏𝑒𝑠𝑒 0 0.01 (0.0008, 0.03) 0.05 (0.02, 0.08) 0.94 (0.91, 0.97) ]
Black Females Ages 46 to 55 (CARDIA) 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0 0 0
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0 0.73 (0.63, 0.82) 0.23 (0.15, 0.30) 0.04 (0.03, 0.07)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0.07 (0.03, 0.11) 0.67 (0.60, 0.75) 0.26 (0.19, 0.34)
𝑂𝑏𝑒𝑠𝑒 0 0.004 (0.0009, 0.01) 0.04 (0.02, 0.06) 0.96 (0.94, 0.98)]
Schell 38 
White Females Ages 46 to 55 (CARDIA) 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0 0 0
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0 0.90 (0.87, 0.93) 0.09 (0.06, 0.12) 0.009 (0.006, 0.013)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0 0.11 (0.07, 0.15) 0.74 (0.68, 0.79) 0.15 (0.12, 0.20)
𝑂𝑏𝑒𝑠𝑒 0 0.004 (0.001, 0.01) 0.05 (0.02, 0.073) 0.95 (0.92, 0.97) ]
White Females Ages 46 to 55 (ARIC) 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.50(.33, .68) 0.45(0.29,0.59) 0.05(0.03,0.07) 0.003(0.002,0.005)
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.006(0.003,0.01) 0.81 (0.79, 0.83) 0.17 (0.15, 0.19) 0.02 (0.01, 0.02)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.0003(0.0001,0.0005) 0.08 (0.07, 0.10) 0.76 (0.73, 0.78) 0.16 (0.14, 0.17)
𝑂𝑏𝑒𝑠𝑒 0.00002(0.000008,0.00006) 0.008 (0.004, 0.01) 0.07 (0.05, 0.08) 0.93 (0.91, 0.94) ]
White Males Ages 46 to 55 (ARIC) 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.41(0.01,0.85) 0.45(0.006,0.77) 0.14(0.02,0.45) 0.008(0.002,0.02)
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.001(0.0000,0.004) 0.78 (0.75, 0.81) 0.20 (0.18, 0.23) 0.04 (0.03, 0.04)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.0006(0.0000,0.0019) 0.07 (0.05, 0.08) 0.82 (0.80, 0.84) 0.19 (0.16, 0.23)
𝑂𝑏𝑒𝑠𝑒 0.00004(0.0000,0.0001) 0.004 (0.003, 0.005) 0.10 (0.08, 0.12) 0.95 (0.93, 0.96) ]
Black Females Ages 46 to 55 (ARIC) 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.50(0.18,0.88) 0.40(0.09,0.64) 0.09(0.02,0.17) 0.008(0.002,0.02)
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.03(0.01,0.05) 0.66 (0.60, 0.72) 0.28 (0.23, 0.33) 0.04 (0.03, 0.04)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.003(0.0006,0.007) 0.06 (0.04, 0.09) 0.74 (0.70, 0.78) 0.19 (0.16, 0.23)
𝑂𝑏𝑒𝑠𝑒 0.00008(0.00002,0.0003) 0.003 (0.001, 0.006) 0.05 (0.03, 0.06) 0.95 (0.93, 0.96) ]
Black Males Ages 46 to 55 (ARIC) 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.64(0.04,1) 0.32(0,0.81) 0.04(0,0.15) 0.002(0,0.009)
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.004(0,0.01) 0.79 (0.73, 0.83) 0.19 (0.15, 0.24) 0.02 (0.01, 0.02)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.002(0,0.007) 0.07 (0.05, 0.10) 0.80 (0.76, 0.84) 0.13 (0.10, 0.16)
𝑂𝑏𝑒𝑠𝑒 0.0002(0,0.0006) 0.005 (0.003, 0.008) 0.11 (0.08, 0.15) 0.88 (0.84, 0.92)]
White Females Ages 56 to 64 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.53(0.04,1) 0.41(0,0.81) 0.05(0.03,0.07) 0.003(0.002,0.004)
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.005(0.001756,0.0098036) 0.81 (0.79, 0.82) 0.17 (0.15, 0.19) 0.01 (0.01, 0.02)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.0003(0.00009,0.0005) 0.09 (0.07, 0.10) 0.77 (0.75, 0.79) 0.14 (0.12, 0.15)
𝑂𝑏𝑒𝑠𝑒 0.0007(0.000004,0.003) 0.005 (0.003,0.007) 0.08 (0.06, 0.09) 0.92 (0.90, 0.93) ]
Schell 39 
White Males Ages 56 to 64 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.53(0.04,1) 0.41(0,0.81) 0.05(0,0.14) 0.002(0,0.007)
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.005(0.002,0.01) 0.79 (0.77, 0.82) 0.19 (0.17, 0.21) 0.01 (0.001, 0.01)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.0003(0.00009,0.0005) 0.06 (0.05, 0.07) 0.83 (0.81, 0.84) 0.11 (0.10, 0.12)
𝑂𝑏𝑒𝑠𝑒 0.0007(0.000004,0.003) 0.004 (0.003, 0.006) 0.10 (0.09, 0.12) 0.89 (0.87, 0.91) ]
Black Females Ages 56 to 64 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 1 0 0 0
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.01(0,0.03) 0.75 (0.67, 0.81) 0.22 (0.16, 0.28) 0.03 (0.02, 0.04)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.0004(0,0.001) 0.07 (0.04, 0.09) 0.73 (0.70, 0.77) 0.20 (0.16, 0.24)
𝑂𝑏𝑒𝑠𝑒 0.00002(0,0.00006) 0.003 (0.002, 0.007) 0.07 (0.05, 0.09) 0.93 (0.91, 0.95)]
Black Males Ages 56 to 64 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 1 0 0 0
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.005(0,0.01) 0.79 (0.74, 0.85) 0.19 (0.13, 0.24) 0.02 (0.01, 0.0.02)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.0003(0,0.0009) 0.09 (0.06, 0.12) 0.77 (0.73, 0.81) 0.14 (0.11, 0.18)
𝑂𝑏𝑒𝑠𝑒 0.00002(0,0.00009) 0.008 (0.005, 0.02) 0.12 (0.08, 0.16) 0.87 (0.28, 0.91) ]
White Females Ages 65 to 75 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.65(0.40,0.89) 0.31(0.10,0.54) 0.032(0.01,0.06) 0.002(0.0004,0.003)
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.01(0.004,0.08) 0.82 (0.79, 0.85) 0.16 (0.13, 0.18) 0.01 (0.008, 0.01)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.0007(0.0003,0.001) 0.11 (0.08, 0.13) 0.78 (0.75, 0.81) 0.11 (0.09, 0.14)
𝑂𝑏𝑒𝑠𝑒 0.00003(0.00001,0.00006) 0.007 (0.005, 0.009) 0.09 (0.07, 0.12) 0.90 (0.87, 0.93) ]
White Males Ages 65 to 75 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.42(0.01,1) 0.39(0,0.83) 0.17(0,0.61) 0.01(0,0.05)
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.004(0,0.01) 0.84 (0.80, 0.87) 0.15 (0.12, 0.18) 0.009 (0.006, 0.01)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.0009(0,0.003) 0.07 (0.06, 0.09) 0.83 (0.81, 0.85) 0.10 (0.08, 0.12)
𝑂𝑏𝑒𝑠𝑒 0.00006(0,0.0003) 0.005 (0.003, 0.007) 0.11 (0.08, 0.14) 0.89 (0.85, 0.92) ]
Black Females Ages 65 to 75 
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[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.50(0.03,1) 0.43(0,0.81) 0.06(0,0.19) 0.004(0,0.02)
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.03(0,0.07) 0.74 (0.63, 0.84) 0.21 (0.12, 0.31) 0.02 (0.007, 0.04)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.003(0,0.008) 0.12 (0.08, 0.18) 0.77 (0.71, 0.84) 0.10 (0.06, 0.15)
𝑂𝑏𝑒𝑠𝑒 0.0001(0,0.0005) 0.009 (0.005, 0.02) 0.10 (0.059, 0.13) 0.90 (0.85, 0.93) ]
Black Males Ages 65 to 75 
[
𝐹𝑟𝑜𝑚/𝑇𝑜 𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑏𝑒𝑠𝑒
𝑈𝑛𝑑𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.65(0.09,1) 0.0008(0,0.003) 0.03(0,0.10) 0.32(0,0.83)
𝑁𝑜𝑟𝑚𝑎𝑙 𝑊𝑒𝑖𝑔ℎ𝑡 0.02(0,0.05) 0.89 (0.83, 0.95) 0.09 (0.04, 0.15) 0.007 (0.001, 0.02)
𝑂𝑣𝑒𝑟𝑤𝑒𝑖𝑔ℎ𝑡 0.001(0,0.003) 0.07 (0.03, 0.11) 0.85 (0.79, 0.91) 0.07 (0.03, 0.12)
𝑂𝑏𝑒𝑠𝑒 0.01(0,0.035) 0.006 (0.002, 0.01) 0.14 (0.07, 0.22) 0.85 (0.77, 0.92) ]
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